News 2015-03-26
Passion at Chongqing International Marathon
75 athletes from Porton joined in the Chongqing International Marathon held on Mar. 22nd, 2015. It’s the first time to participate the marathon race for most of them, but they all exceeded the result estimated themselves before the race. They all expressed the marathon’s spirit of perseverance and transcending oneself. As the CEO Oliver Ju said, the colorful life comes from the constant self-challenges and Porton’s future comes from constantly transcend ourselves.
Others
More
News 2026-08-05
Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization
Porton Advanced Solutions Ltd. has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton Advanced to undertake commercial contract manufacturing for Cell and Gene Therapy (CGT) products, extending its CDMO services from process development and clinical production through to the commercialization stage.
News 2026-07-08
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
